|Bid||125.27 x 800|
|Ask||127.06 x 1100|
|Day's Range||119.05 - 127.58|
|52 Week Range||53.40 - 140.89|
|Beta (5Y Monthly)||1.37|
|PE Ratio (TTM)||689.35|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Shares of Novocure (NASDAQ: NVCR) were sinking 9.2% as of 3:30 p.m. on Tuesday. The oncology therapy company didn't announce any news, so why did the stock fall on a day when the overall market soared? The most likely reason is that some investors decided to lock in profits after Novocure's year-to-date gain of nearly 60% as of the market close on Monday.
Novocure sold off hard today in heavy volume to the 50-day//below the 10-week line. NVCR had been looking very good, crossing several early buy points --- after a strong run. No apparent news.
Rebounds from the 10-week line and breaking trend lines offer ways to start early positions in leaders. AMD, Twilio and Novocure offer both buy signals now.